Changes in leukocyte gene expression profiles induced by antineoplastic chemotherapy

Oncology Letters

Volumn 3, Issue 6, 2012, Pages 1341-1349

  González Fernández, Rebeca ^a   Morales, Manuel ^b,c   Avila, Julio ^a   Martín Vasallo, Pablo ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c HOSPITEN Rambla   (Spain)

Author keywords

Carboplatin; Chemotherapy; Gene expression; Leukocyte; Paclitaxel

Indexed keywords

ATM PROTEIN; CARBOPLATIN; COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; DOXORUBICIN; INITIATION FACTOR 4B; MATRIN 3; MESSENGER RNA; MICRORCHIDIA 3; PACLITAXEL; PROGRAMMED CELL DEATH GENE 10 PROTEIN; PROTEASOME SUBUNIT TYPE BETA; PROTEIN; PROTEIN LEVO ISOASPARTATE O METHYLTRANSFERASE; REQUIRED FOR MEIOTIC NUCLEAR DIVISION 5 HOMOLOGUE A; SUPPRESSOR OF ACTIN MUTATIONS 1 LIKE PROTEIN; TRANSCRIPTION FACTOR RUNX2; TRANSMEMBRANE PROTEIN 66; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN 644;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL SURVIVAL; DNA LIBRARY; FOLLOW UP; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; LEUKOCYTE; MOLECULAR CLONING; MULTIPLE CYCLE TREATMENT; PROGNOSIS; RECEPTOR UPREGULATION; RNA ISOLATION;

EID: 84859464801     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.669     Document Type: Article

References (39)

1. De Vita V (author), DePinho RA (ed), Lawrence TS (ed), Rosenberg SA (ed) and Weinberg RA (ed): DeVita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology. 9th edition, Lippincott Williams & Wilkins, Philadelphia, 2011.
2. Perry MC (ed): The Chemotherapy Source Book. 4th edition. Lippincott Williams & Wilkins, Philadelphia, 2008.
3. Kavallaris M, Kuo DY, Burkhart CA, et al: Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J Clin Invest 100: 1282-1293, 1997.
4. Steffensen KD, Waldstrom M and Jakobsen A: The relationship of platinum resistance and ERCC1 protein expression in epithelial ovarian cancer. Int J Gynecol Cancer 19: 820-825, 2009.
5. Smith L, Watson MB, O'Kane SL, Drew PJ, Lind MJ and Cawkwell L: The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays. Mol Cancer Ther 5: 2115-2120, 2006.
6. Watts GS, Futscher BW, Isett R, Gleason-Guzman M, Kunkel MW and Salmon SE: cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. J Pharmacol Exp Ther 299: 434-441, 2001.
7. Ekhart C, Doodeman VD, Rodenhuis S, Smits PH, Beijnen JH and Huitema AD: Influence of polymorphisms of drug metabolizing enzymes (CYP2B6, CYP2C9, CYP2C19, CYP3A4, CYP3A5, GSTA1, GSTP1, ALDH1A1 and ALDH3A1) on the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide. Pharmacogenet Genomics 18: 515-523, 2008.
8. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: A Laboratory Manual. 2nd edition. Cold Spring Harbor Laboratory, 1989.
9. Altschul SF, Madden TL, Schaffer AA, et al: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25: 3389-3402, 1997.
10. Velculescu VE, Zhang L, Vogelstein B and Kinzler KW: Serial analysis of gene expression. Science 270: 484-487, 1995.
11. Liang P and Pardee AB: Differential display of mRNA by PCR. Curr Protoc Mol Biol, Chapter 25: Unit 25B.3. 2001.
12. Diatchenko L, Lau YF, Campbell AP, et al: Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93: 6025-6030, 1996.
13. Bensimon A, Aebersold R and Shiloh Y: Beyond ATM: the protein kinase landscape of the DNA damage response. FEBS Lett 585: 1625-1639, 2011.
14. Lavin MF: Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 9: 759-769, 2008.
15. Parsyan A, Svitkin Y, Shahbazian D, et al: mRNA helicases: the tacticians of translational control. Nat Rev Mol Cell Biol 12: 235-245, 2011.
16. Przygodzka P, Boncela J and Cierniewski CS: Matrin 3 as a key regulator of endothelial cell survival. Exp Cell Res 317: 802-811, 2011.
17. Valencia CA, Ju W and Liu R: Matrin 3 is a Ca2+/calmodulin-binding protein cleaved by caspases. Biochem Biophys Res Commun 361: 281-286, 2007.
18. Kula A, Guerra J, Knezevich A, Kleva D, Myers MP and Marcello A: Characterization of the HIV-1 RNA associated proteome identifies Matrin 3 as a nuclear cofactor of Rev function. Retrovirology 8: 60, 2011.
19. Takahashi K, Yoshida N, Murakami N, et al: Dynamic regulation of p53 subnuclear localization and senescence by MORC3. Mol Biol Cell 18: 1701-1709, 2007.
20. Shimizu T, Matsuoka Y and Shirasawa T: Biological significance of isoaspartate and its repair system. Biol Pharm Bull 28: 1590-1596, 2005.
21. Young GW, Hoofring SA, Mamula MJ, et al: Protein L-isoaspartyl methyltransferase catalyzes in vivo racemization of Aspartate-25 in mammalian histone H2B. J Biol Chem 280: 26094-26098, 2005.
22. Carter WG and Aswad DW: Formation, localization, and repair of L-isoaspartyl sites in histones H2A and H2B in nucleosomes from rat liver and chicken erythrocytes. Biochemistry 47: 10757-10764, 2008.
23. Lauenborg B, Kopp K, Krejsgaard T, et al: Programmed cell death-10 enhances proliferation and protects malignant T cells from apoptosis. APMIS 118: 719-728, 2010.
24. Ma X, Zhao H, Shan J, et al: PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway. Mol Biol Cell 18: 1965-1978, 2007.
25. Aguirre AJ, Brennan C, Bailey G, et al: High-resolution characterization of the pancreatic adenocarcinoma genome. Proc Natl Acad Sci USA 101: 9067-9072, 2004.
26. Huerta S, Harris DM, Jazirehi A, et al: Gene expression profile of metastatic colon cancer cells resistant to cisplatin-induced apoptosis. Int J Oncol 22: 663-670, 2003.
27. Keutgens A, Zhang X, Shostak K, et al: BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1. J Biol Chem 285: 25831-25840, 2010.
28. Kobayashi N, Yang J, Ueda A, et al: RanBPM, Muskelin, p48EMLP, p44CTLH, and the armadillo-repeat proteins ARMC8alpha and ARMC8beta are components of the CTLH complex. Gene 396: 236-247, 2007.
29. Pratap J, Lian JB, Javed A, et al: Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev 25: 589-600, 2006.
30. Eliseev RA, Dong YF, Sampson E, et al: Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis. Oncogene 27: 3605-3614, 2008.
31. Rohde HM, Cheong FY, Konrad G, Paiha K, Mayinger P and Boehmelt G. The human phosphatidylinositol phosphatase SAC1 interacts with the coatomer I complex. J Biol Chem 278: 52689-52699, 2003.
32. Liu Y, Boukhelifa M, Tribble E, et al: The Sac1 phosphoinositide phosphatase regulates Golgi membrane morphology and mitotic spindle organization in mammals. Mol Biol Cell 19: 3080-3096, 2008.
33. Blagoveshchenskaya A, Cheong FY, Rohde HM, et al: Integration of Golgi trafficking and growth factor signaling by the lipid phosphatase SAC1. J Cell Biol 180: 803-812, 2008.
34. Mori T, Nishimura N, Hasegawa D, et al: Persistent detection of a novel MLL-SACM1L rearrangement in the absence of leukemia. Leuk Res 34: 1398-1401, 2010.
35. Romanuik TL, Ueda T, Le N, et al: Novel biomarkers for prostate cancer including noncoding transcripts. Am J Pathol 175: 2264-2276, 2009.
36. Romanuik TL, Wang G, Holt RA, Jones SJ, Marra MA and Sadar MD: Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries. BMC Genomics 10: 476, 2009.
37. Mannherz O, Mertens D, Hahn M and Lichter P: Functional screening for proapoptotic genes by reverse transfection cell array technology. Genomics 87: 665-672, 2006.
38. Mulligan P, Westbrook TF, Ottinger M, et al: CDYL bridges REST and histone methyltransferases for gene repression and supp-ression of cellular transformation. Mol Cell 32: 718-726, 2008.
39. Matsumoto K, Ishii N, Yoshida S, Shiosaka S, Wanaka A and Tohyama M: Molecular cloning and distinct developmental expression pattern of spliced forms of a novel zinc finger gene wiz in the mouse cerebellum. Brain Res Mol Brain Res 61: 179-189, 1998.